Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- CNRS
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- KTH Royal Institute of Technology
- Leiden University
- Lunds universitet
- Maastricht University (UM)
- Malmö universitet
- NIBRT
- NTNU Norwegian University of Science and Technology
- Technical University Of Denmark
- Technical University of Denmark
- University of Cambridge
- University of Colorado
- Uppsala universitet
- 4 more »
- « less
-
Field
-
by phage display, and the production of nanobodies and their mutants (https://research.pasteur.fr/fr/team/antibody-engineering/ ). Call for applications: PhD thesis on “the generation, characterization
-
. The research group, led by Professor Thoas Fioretos , consists of about ten members with expertise in advanced flow cytometry, single-cell analysis, bioinformatics, antibody technology, and experimental systems
-
of novel payloads and to engineering monoclonal antibodies. Yet one critical component (the linker) remains comparatively under-explored. Linkers govern the controlled release of potent payloads inside
-
5 Jan 2026 Job Information Organisation/Company NTNU Norwegian University of Science and Technology Department The Department of Clinical and Molecular Medicine (IKOM) Research Field Medical
-
19 Dec 2025 Job Information Organisation/Company Maastricht University (UM) Research Field Chemistry » Analytical chemistry Chemistry » Applied chemistry Engineering » Biomedical engineering
-
for graphene. Engineer antibodies/nanobodies, aptamers and dCas9 to retain target binding after immobilization on graphene/oxo-graphene. Validate engineered molecules in binding assays and after conjugation with
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 20 days ago
/FCT/i3S/2312/2025 A call is opened for the position of a PhD holder, for an unfixed term work contract to carry out research duties within the project “PSGL-1 immune checkpoint protein antibody blockade
-
antibodies/nanobodies, aptamers and dCas9 to retain target binding after immobilization on graphene/oxo-graphene. Validate engineered molecules in binding assays and after conjugation with nanomaterials
-
, postdoctoral researchers, and scientists work closely together on the engineering and production of biological molecules such as antibodies, Affibody molecules, and adeno-associated viruses for therapeutic
-
engineer adoptive cell therapies. This project will create biotherapeutic production cell lines and tools to program the host cell to engineer in or out specific mRNA methylation events in a targeted manner